1.Expert consensus on standardized medical order review of parenteral nutrition
Bing GAN ; Tong LI ; Xueqiong ZHENG ; Ying WANG ; Jiefang CAI ; Qiuliang MAI ; Dan GUO ; Zhuo CAI ; Cailing HUANG
China Pharmacy 2026;37(21):2765-2777
OBJECTIVE To standardize the medical order review for parenteral nutrition (PN) in medical institutions, establish unified review standards and operating procedures, and provide a reference for clinical practice.METHODS Under the organization of the Committee of Clinical Pharmacy, Guangdong Liver Disease Association and the Committee of Oncology Clinical Pharmacy, China Anti-cancer Association, experts in relevant fields across China were convened. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) method was adopted for evidence grading and recommendation strength classification. Through the Delphi method combined with the consensus conference method, multiple rounds of discussion and voting were conducted around the key issues of PN medical order review, and the Expert Consensus on Standardized Medical Order Review of Parenteral Nutrition (hereinafter referred to as the Consensus ) was finally developed.RESULTS The Consensus elaborated on three core stages: pre-review assessment, review process, and post-review management, covering such aspects as basic review principles, indications and contraindications review, components and proportions review, stability and compatibility review, infusion regimen review, and special populations review. A total of 10 clinical questions were raised and 33 recommendations were formulated, with the evidence level and recommendation strength for each item explicitly specified.CONCLUSIONS The Consensus systematically outlined the standard operating pathways for PN medical order review and clarified the review key points and judgment criteria for each stage, providing operable practical guidance for pharmacists in medical institutions at all levels to conduct PN medical order review, and helping to promote the standardization and homogenization of PN medical order review.
2.Intermittent hypoxia aggravates asthma inflammation via NLRP3/IL-1β-dependent pyroptosis mediated by HIF-1α signalling pathway.
Ling ZHOU ; Huojun ZHANG ; Lu LIU ; Fengqin ZHANG ; Lingling WANG ; Pengdou ZHENG ; Zhenyu MAO ; Xiaoyan ZHU ; Guisha ZI ; Lixiang CHEN ; Xiaojing CAI ; Huiguo LIU ; Wei LIU
Chinese Medical Journal 2025;138(14):1714-1729
BACKGROUND:
Asthma is a common chronic inflammatory airway disease and intermittent hypoxia is increasingly recognized as a factor that may impact disease progression. The present study investigated whether intermittent hypoxia (IH) could aggravate asthma by promoting hypoxia-inducible factor-1α (HIF-1α)/nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain-containing protein 3 (NLRP3)/interleukin (IL)-1β-dependent pyroptosis and the inflammatory response and further elucidated the underlying molecular mechanisms involved.
METHODS:
A total of 49 patients diagnosed with severe bronchial asthma and diagnosed by polysomnography were enrolled at Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, between January 2022 and December 2022, and their general data and induced sputum were collected. BEAS-2B cells were treated with IL-13 and subjected to IH. An ovalbumin (OVA)-treated mouse model was also used to assess the effects of chronic intermittent hypoxia (CIH) on asthma. Pyroptosis, the inflammatory response, and related signalling pathways were assessed in vivo and in vitro .
RESULTS:
In this study, as the apnoea and hypopnea index (AHI) increased, the proportion of patients with uncontrolled asthma increased. The proportions of neutrophils and the levels of IL-6, IL-8, HIF-1α and NLRP3 in induced sputum were related to the AHI. NLRP3-mediated pyroptosis, which could be mediated by the HIF-1α signalling pathway, was activated in IL-13 plus IH-treated BEAS-2B cells and in the lungs of OVA/CIH mice. HIF-1α downregulation significantly reduced lung pyroptosis and ameliorated neutrophil inflammation by modulating the NLRP3/IL-1β pathway both in vitro and in vivo . Similarly, pretreatment with LW6, an inhibitor of HIF-1α, effectively blocked the generation of inflammatory cytokines in neutrophils. In addition, administration of the NLRP3 activator nigericin obviously increased lung neutrophil inflammation.
CONCLUSIONS
Obstructive sleep apnoea-hypopnea syndrome (OSAHS) is a risk factor for asthma exacerbation. IH aggravates neutrophil inflammation in asthma via NLRP3/IL-1β-dependent pyroptosis mediated by the HIF-1α signalling pathway, which should be considered a potential therapeutic target for the treatment of asthma with OSAHS.
NLR Family, Pyrin Domain-Containing 3 Protein/metabolism*
;
Humans
;
Asthma/metabolism*
;
Animals
;
Pyroptosis/physiology*
;
Hypoxia-Inducible Factor 1, alpha Subunit/metabolism*
;
Mice
;
Signal Transduction/physiology*
;
Male
;
Hypoxia/metabolism*
;
Female
;
Interleukin-1beta/metabolism*
;
Adult
;
Inflammation/metabolism*
;
Middle Aged
;
Mice, Inbred C57BL
3.Clinical experience of 1064 cases of severe acute pancreatitis: medical treatment predominant therapy
Yiqi DU ; Xianbao ZHAN ; Pei XIE ; Yuanhang DONG ; Yan CHEN ; Qihong YU ; Xiaorong GUO ; Jiefang GUO ; Wenjun ZHANG ; Xingang SHI ; Jianping LI ; Ye CAI ; Shengdao ZHANG ; Zhaoshen LI
Chinese Journal of Pancreatology 2012;(6):366-370
Objective To evaluate the value of medical treatment in the management of SAP.Methods From January 2000 to December 2011,a total of 1064 cases out of 931 SAP patients were admitted and retrospectively analyzed.The etiologies,severity score,complication rates,therapies,effectiveness and costs of those SAP cases were summarized.Results There were 559 males and 372 females with a mean age of (51 ± 15)years old.The main cause was biliary tract disease (58.3%),followed by fat-rich diet (31.2%),hyperlipidemia (13.6%) and alcohol (7.1%).At the time of admission,95.5% of SAP patients presented with level D disease according to Balthazar CT severity index,26.0% had a Ranson score ≥3 and 30.1% had an APACHE Ⅱ score ≥ 8.There were 42.7% cases complicated with systemic inflammatory response syndrome (SIRS).Acute lung injury and acute respiratory distress syndrome (ARDS),acute kidney injury,shock or heart failure,acute liver dysfunction,and diffuse intravascular clotting (DIC)occurred in 24.0%,8.1%,5.4%,3.2%,and 1% of all patients,respectively.Other complications of SAP included abdominal cavity bleeding (n =17),pseudocyst bleeding (n =9),pancreatic abscess (n =78) and gastrointestinal fistula (n =33).Totally 25 (2.3%) patients died in hospital and 36 (3.4%) patients were discharged against advice,with an overall treatment success rate of 94.3%.The mean hospital stay was (23.7 ± 19.2) d,and the average cost was 52.3 thousands of RMB.Conclusions A comprehensive treatment pathway relying on medical treatment,focusing on organ function support and assisted by miniinvasive intervention may improve the treatment success rate of SAP,which is worth of further application.
4.3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage.
Jun-Fu ZHOU ; Ye-Hua ZHOU ; Liang ZHANG ; Huai-Hong CHEN ; Dong CAI
Biomedical and Environmental Sciences 2003;16(1):53-61
OBJECTIVETo investigate whether 3,4-methylenedioxymethamphetamine (MDMA) abuse produces another neurotoxicity which may significantly inhibit the acetylcholinesterase activity and result in severe oxidative damage and liperoxidative damage to MDMA abusers.
METHODS120 MDMA abusers (MA) and 120 healthy volunteers (HV) were enrolled in an independent sample control design, in which the levels of lipoperoxide (LPO) in plasma and erythrocytes as well as the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and acetylcholinesterase (AChE) in erythrocytes were determined by spectrophotometric methods.
RESULTSCompared with the average values of biochemical parameters in the HV group, those of LPO in plasma and erythrocytes in the MA group were significantly increased (P < 0.0001), while those of SOD, CAT, GPX and AChE in erythrocytes in the MA group were significantly decreased (P < 0.0001). The Pearson product-moment correlation analysis between the values of AChE and biochemical parameters in 120 MDMA abusers showed that significant linear negative correlation was present between the activity of AChE and the levels of LPO in plasma and erythrocytes (P < 0.0005-0.0001), while significant linear positive correlation was observed between the activity of AchE and the activities of SOD, CAT and GPX (P < 0.0001). The reliability analysis for the above biochemical parameters reflecting oxidative and lipoperoxidative damages in MDMA abusers suggested that the reliability coefficient (alpha) was 0.8124, and that the standardized item alpha was 0.9453.
CONCLUSIONThe findings in the present study suggest that MDMA abuse can induce another neurotoxicity that significantly inhibits acetylcholinesterase activity and aggravates a series of free radical chain reactions and oxidative stress in the bodies of MDMA abusers, thereby resulting in severe neural, oxidative and lipoperoxidative damages in MDMA abusers.
Acetylcholinesterase ; metabolism ; Adolescent ; Adult ; Amphetamine-Related Disorders ; blood ; enzymology ; metabolism ; Catalase ; blood ; Cholinesterase Inhibitors ; adverse effects ; urine ; Erythrocytes ; enzymology ; Female ; Humans ; Lipid Peroxidation ; drug effects ; Lipid Peroxides ; blood ; Male ; N-Methyl-3,4-methylenedioxyamphetamine ; adverse effects ; urine ; Oxidative Stress ; drug effects ; Superoxide Dismutase ; blood
5.Abnormal reactions of free radicals and oxidative damages in the bodies of patients with chronic glomerulonephritis.
Jun-Fu ZHOU ; Jia-Xi CHEN ; Han-Chao SHEN ; Dong CAI
Biomedical and Environmental Sciences 2002;15(3):233-244
OBJECTIVETo study the abnormal reactions of a series of free radicals and the oxidative damages induced by free radical abnormal reactions in the bodies of patients with chronic glomerulonephritis.
METHODSEighty chronic glomerulonephritis patients (CGNP) and eighty healthy adult volunteers (HAV) were enrolled in a random control study, in which concentrations of nitric oxide (NO) in plasma, lipoperoxides (LPO) in plasma and in erythrocytes, and vitamin C (VC), vitamin E (VE) and beta-carotene (beta-CAR) in plasma as well as activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX) in erythrocytes were determined with spectrophotometric assays.
RESULTSCompared with the average values of the above biochemical parameters in the HAV group, the average values of NO in plasma, and LPO in plasma and erythrocytes in the CGNP group were significantly increased (P = 0.0001), while those of VC, VE and beta-CAR in plasma as well as those of SOD, CAT and GPX in erythrocytes in the CGNP group were significantly decreased (P = 0.0001). Pearson product-moment correlation analysis showed that with increase of the concentration of blood creatinine as well as prolongation of the course of disease in the CGNP, the concentrations of NO in plasma, and LPO in plasma and erythrocytes in the CGNP increased gradually, while the concentrations of VC, VE and beta-CAR in plasma as well as the activities of SOD, CAT and GPX in erythrocytes in the CGNP decreased gradually (P = 0.002454-0.000001). The relative risk ratio (RR) of the above biochemical parameters reflecting oxidative damages in the bodies of CGNP ranged from 6.061 to 72.429. The reliability coefficient (alpha) that the above biochemical parameters were used to reflect the oxidative damages of the CGNP was 0.8137, standardized item alpha = 0.9728, Hotelling's T-Squared = 1135680.191, F = 53274.6478, P = 0.000001.
CONCLUSIONSThe findings in this study show that in the bodies of CGNP a series of free radical chain reactions result in severe pathological aggravation and induce oxidative damages in their bodies. Therefore, suitable dose of antioxidants should be supplemented to them so as to alleviate oxidative damages in their bodies.
Adult ; Antioxidants ; pharmacology ; therapeutic use ; Catalase ; pharmacology ; Chronic Disease ; Erythrocytes ; enzymology ; Female ; Free Radicals ; adverse effects ; Glomerulonephritis ; physiopathology ; Glutathione Peroxidase ; pharmacology ; Humans ; Lipid Peroxidation ; Male ; Nitric Oxide ; adverse effects ; analysis ; Oxidation-Reduction ; Oxidative Stress ; Superoxide Dismutase ; pharmacology

Result Analysis
Print
Save
E-mail